Fig. 2From: mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysisRisk of bias summary: review authors’ judgements about each risk of bias item for each included studyBack to article page